April twenty eighth, 2026 – Dubai, UAE
Constructed on Symbiotic Core and built-in into Midas’ Open Liquidity Structure, the partnership provides a capital-efficient RFQ settlement layer for tokenized belongings: T+0 atomic settlement with no idle capital and no pre-funded stock.
Most tokenized belongings stay functionally illiquid. Redemptions can take 60 to 180 days or extra, leaving capital frozen between settlement occasions. Tokenization solved entry however deep, dependable liquidity at scale stays the open downside.
Symbiotic and Midas at this time introduced the scope of the Immediate Liquidity product for tokenized belongings, constructed on Symbiotic Core V2. Symbiotic Immediate Liquidity is an RFQ-based liquidity resolution built-in as a part of Midas’ Open Liquidity Structure. It supplies a extremely capital-efficient strategy to onchain RWA redemptions: dedicated capital settles redemptions atomically with out requiring pre-funded stock or idle capital buffers, whereas sustaining its full perform. The answer targets most Midas belongings, together with Fasanara’s mGLOBAL, which was lately launched on the Midas platform.
The mannequin is easy. An asset supervisor submits a redemption request, and Symbiotic-registered market makers and curators reply with bids via an onchain RFQ system. The asset is priced, the most effective bid executes, and settlement completes in a single transaction. Market makers don’t have to pre-fund stock and earn the unfold on execution. The identical system additionally handles lending market liquidations, via Redstone Settle, which have traditionally been a key constraint in DeFi techniques constructed on tokenized belongings.
That is made doable by Symbiotic Core. The upcoming V2 improve introduces capital services, permitting capital in Symbiotic vaults to stay enforceable whereas being deployed between settlement occasions. As a substitute of sitting idle, it may be allotted to whitelisted DeFi protocols like Morpho and Euler and mechanically recalled when obligations set off, enabling instantaneous settlement with out pre-funded liquidity. Another concerned companions embrace Keyring and Time period Finance.
“Liquidity is what turns an asset class right into a market. The RWA house has been constructing towards trillions with out it. Symbiotic Core adjustments that: dedicated capital now features as a liquidity sleeve, settling redemptions with out sitting idle. That is what collateral markets infrastructure is constructed for.” – Misha Putiatin, Co-Founder, Symbiotic
Midas lately closed a $50 million Collection A to construct institutional-grade tokenized monetary merchandise. mGLOBAL is Fasanara’s flagship fund, tokenized on Midas and the primary asset stay on Symbiotic Immediate Liquidity. Built-in inside Midas’ Open Liquidity Structure, this RFQ layer extends present instantaneous redemption capabilities with a totally onchain, capital-efficient settlement pathway open to certified market makers.
“The most important friction level for tokenised merchandise has at all times been redemptions. You’ll be able to put a fund onchain, but when exiting nonetheless takes a number of weeks, you haven’t actually solved something. Symbiotic Immediate Liquidity, as a part of Midas’ Open Liquidity Structure, adjustments that equation. On high of that, the capital backing redemptions is productive till the second it’s wanted, then settles atomically.” – Dennis Dinkelmeyer, Co-Founder & CEO, Midas
Immediate Liquidity is one product on Symbiotic’s collateral markets ecosystem. Cap Labs, working in credit score, and Nexus Mutual, working in insurance coverage, are already stay. Three completely different monetary merchandise, three completely different markets, one shared infrastructure.
Any issuer can combine. Any market maker can take part.
About Symbiotic
Symbiotic powers collateral markets, the place capital is dedicated to monetary obligations and enforced by code. Capital stays productive whereas dedicated, eradicating the tradeoff between being locked and incomes. It backs merchandise throughout credit score, insurance coverage, stablecoins, and RWA. Symbiotic powers 80+ vaults, 74,000+ energetic stakers, and 111 operators, with Chainlink, Nexus Mutual, and Cap Labs stay in manufacturing. Backed by Paradigm, Pantera, Cyber.fund and Coinbase Ventures.
About Midas
Midas is a platform for composable onchain funding merchandise that permits technique managers to tokenise their institutional methods. These “mTokens” supply buyers full transparency, instantaneous redemptions, and native composability throughout DeFi protocols similar to Morpho and Pendle. Based in 2024 by Dennis Dinkelmeyer (previously Goldman Sachs), Fabrice Grinda (FJ Labs), and Romain Bourgois (previously Ondo Finance), Midas is backed by main buyers together with RRE, Creandum, Framework Ventures, HV Capital, Ledger Cathay and Coinbase Ventures. The corporate lately secured $50M in Collection A funding, constructing on a observe document that features over $1.7B in asset issuance and $37M in yield paid out to this point.
Contact
Mia Adriaens
Symbiotic
[email protected]
This content material is sponsored and must be considered promotional materials. Opinions and statements expressed herein are these of the writer and don’t mirror the opinions of The Each day Hodl. The Each day Hodl will not be a subsidiary of or owned by any ICOs, blockchain startups or firms that publicize on our platform. Buyers ought to do their due diligence earlier than making any high-risk investments in any ICOs, blockchain startups or cryptocurrencies. Please be suggested that your investments are at your individual danger, and any losses you might incur are your duty.
